#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Evaluation of Three Amikacin Administration Regimens byPharmacokinetic Modelling in Patients with Cystic Fibrosis


Authors: M. Halačová;  R. Průša;  K. Kotaška;  V. Vávrová 1
Authors‘ workplace: Ústav klinické biochemie a patobiochemie 2. LF UK a FNM, Praha 1II. dětská klinika 2. LF UK a FNM, Praha
Published in: Čas. Lék. čes. 2004; : 187-190
Category:

Overview

Background.
Once-daily administration of aminoglykosides is routinely used, but comparative efficacy data forpatients with cystic fibrosis are not available.Methods and Results. The aim of the this study was to compare the predicted pharmacodynamic (PD) activity ofamikacin at 28 mg/kg/den administered every 24 hod.(q24 h), q12 h, and q8 h. Pharmacokinetic (PK) data werederived from analysis of the amikacin serumconcentration from42 CF children patients. Individual pharmacokineticsvalues were used to construct serum concentration-versus time curves and to determine various indices (c peak/MICratio and time during the concentration was less than theMIC – T

Key words:
cystic fibrosis, amikacin, pharmacokinetic parameters, MIC.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist

Article was published in

Journal of Czech Physicians


Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#